GLIOBLASTOMA, ISOCITRIC DEHYDROGENASE (IDH)-WILDTYPE

Clinical trials for GLIOBLASTOMA, ISOCITRIC DEHYDROGENASE (IDH)-WILDTYPE explained in plain language.

Never miss a new study

Get alerted when new GLIOBLASTOMA, ISOCITRIC DEHYDROGENASE (IDH)-WILDTYPE trials appear

Sign up with your email to follow new studies for GLIOBLASTOMA, ISOCITRIC DEHYDROGENASE (IDH)-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists use ultrasound to unlock brain, supercharge cancer fight

Disease control Recruiting now

This study is testing a new approach for treating glioblastoma, a very aggressive brain cancer. Researchers are implanting a small ultrasound device in the brain to temporarily open the protective blood-brain barrier. The goal is to allow powerful immune-boosting drugs to better …

Matched conditions: GLIOBLASTOMA, ISOCITRIC DEHYDROGENASE (IDH)-WILDTYPE

Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

GLIOBLASTOMA, ISOCITRIC DEHYDROGENASE (IDH)-WILDTYPE

Get alerted when new GLIOBLASTOMA, ISOCITRIC DEHYDROGENASE (IDH)-WILDTYPE trials appear

Scientists use ultrasound to unlock brain, supercharge cancer fight